RxDoctor Payments Data

Daniel Black, DO

Family Medicine · Dayton, TNNPI 1194726604

Payments from drug & device makers

$781in general payments, 2019–2025

Across 49 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$216
  • Bausch Health US, LLC$212
  • Lilly USA, LLC$136
  • Novo Nordisk$101
  • Otsuka America Pharmaceutical, Inc.$69
  • Pfizer$35
  • plus $12 from 1 others

What the payments were for

  • Food & beverage$781100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$781 in reported general payments places this provider in the 55th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$174,099
Medicare patients
339
Services billed
2,287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban175$118,280
OzempicSemaglutide20$35,810
MounjaroTirzepatide26$27,868
TrulicityDulaglutide15$17,765
JardianceEmpagliflozin22$16,534
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$14,348
Solifenacin Succinate47$12,026
GlyxambiEmpagliflozin/Linagliptin12$6,878
Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp29$6,051
Rosuvastatin Calcium379$5,094
Nebivolol Hcl64$4,555
Valsartan94$3,731
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$3,574
Omeprazole241$3,501
Famotidine158$2,704

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$35$118,280175 claims
Lilly USA, LLCMounjaro, Trulicity, Humulin 70-30$136$47,46454 claims
Novo NordiskOzempic$101$35,81020 claims
AbbVieSynthroid$216$1,34535 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Dayton

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →